Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 1;53(6):e1346-e1347.
doi: 10.1097/CCM.0000000000006675. Epub 2025 Jun 3.

The authors reply

Asad E Patanwala  1   2 , Xuya Xiao  3   4 , Thomas E Hills  5 , Alisa M Higgins  6 , Colin J McArthur  7 , G Caleb Alexander  3   4   8 , Hemalkumar B Mehta  3   4 ; National Covid Cohort Collaborative (N3C) Consortium
Affiliations

The authors reply

Asad E Patanwala et al. Crit Care Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Hills’ institution received funding from the Health Research Council of New Zealand; he received support for article research from the Health Research Council of New Zealand. Dr. Higgins’ institution received funding from the National Health and Medical Research Council (NHMRC) Investigator Grant (GNT2008447); she received support for article research from the NHMRC. Dr. McArthur received funding from the Health Research Council of New Zealand. Dr. Mehta received support for article research from the National Institutes of Health and the National Institute on Aging (1K01AG070329). The remaining authors have disclosed that they do not have any potential conflicts of interest.

References

    1. Luo P, Lian Y: Baricitinib and tocilizumab in COVID-19: A call for deeper mechanistic and methodological exploration. Crit Care Med. 2025; 53:e1344–e1345
    1. Patanwala AE, Xiao X, Hills TE, et al.; National Covid Cohort Collaborative (N3C) Consortium: Comparative effectiveness of baricitinib versus tocilizumab in hospitalized patients with COVID-19: A retrospective cohort study of the National Covid Collaborative. Crit Care Med. 2025; 53:e29–e41
    1. Forsberg J, Bedard E, Mahmoud SH: Bioavailability of orally administered drugs in critically ill patients. J Pharm Pract. 2022; 36:967–979
    1. National Center for Advancing Translational Sciences/National Institutes of Health/U.S. Department of Health and Human Services: National COVID Cohort Collaborative (N3C). 2023. Available at: https://ncats.nih.gov/n3c/about. Accessed May 10, 2023

LinkOut - more resources